Mohanty D, Colah R B, Gorakshakar A C, Nadkarni A H, Phanasgaonkar S P, Shetty S, Ghosh K, Mukherjee M B
Institute of Immunohaematology, KEM Hospital Campus, Parel, Mumbai, India.
Community Genet. 2002;5(3):197-200. doi: 10.1159/000066336.
Haemoglobinopathies represent a significant national health burden in India. The distribution of specific disorders varies geographically and by community. Heterozygote frequencies of beta-thalassaemia range from 1 to 15%, resulting in an estimated 20 million carriers. HbS is mainly present in tribal and non-caste communities, with carrier prevalences of up to 40%. By comparison, alpha-thalassaemia carriers are found in both the caste and tribal communities, and can reach a frequency of >90% in the latter case. Community control of haemoglobinopathies relies mainly on out-reach education programmes and genetic counselling, with antenatal diagnosis offered in specific major centres. Only partial data are available on the prevalence of haemophilia, but it has been estimated that there are some 50,000 affected individuals nationwide, with an additional 1,500 new cases born each year. RFLP-based techniques have been established to detect mutations in the factor VIII and IX genes, enabling the limited introduction of carrier detection and antenatal diagnosis.
血红蛋白病给印度带来了沉重的国民健康负担。特定疾病的分布因地域和社区而异。β地中海贫血杂合子频率在1%至15%之间,估计携带者达2000万。血红蛋白S主要存在于部落和非种姓社区,携带者患病率高达40%。相比之下,α地中海贫血携带者在种姓和部落社区均有发现,在部落社区频率可达90%以上。血红蛋白病的社区防控主要依靠外展教育项目和遗传咨询,特定主要中心提供产前诊断。血友病患病率仅有部分数据,但据估计全国约有50000名患者,每年新增1500例病例。已建立基于限制性片段长度多态性的技术来检测凝血因子VIII和IX基因的突变,从而有限地开展携带者检测和产前诊断。